50
Participants
Start Date
September 1, 2021
Primary Completion Date
July 1, 2026
Study Completion Date
July 1, 2026
High-flow nasal cannula therapy
High-flow nasal cannula therapy (HFNC) (from 25 - 60 L/min based on patient's tolerance) will be used in 21 participants during one additional sleep study to investigate its acute impact on reducing sleep abnormalities. Inspired fraction of oxygen will be titrated to maintain patient SpO2 similar to the levels during standard oxygen therapy.
RECRUITING
St. Michael's Hospital, Toronto
Unity Health Toronto
OTHER